Guggenheim Capital’s NEOPHOTONICS CORP NPTN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-102,036
| Closed | -$1.6M | – | 2097 |
|
|
2022
Q2 | $1.6M | Buy |
102,036
+24,466
| +32% | +$374K | 0.01% | 995 |
|
|
2022
Q1 | $1.18M | Buy |
77,570
+32,773
| +73% | +$499K | 0.01% | 1275 |
|
|
2021
Q4 | $689K | Buy |
+44,797
| New | +$589K | ﹤0.01% | 1529 |
|
|
2018
Q4 | – | Sell |
-103,195
| Closed | -$857K | – | 2423 |
|
|
2018
Q3 | $857K | Buy |
103,195
+169
| +0.2% | +$1.28K | 0.01% | 1696 |
|
|
2018
Q2 | $641K | Sell |
103,026
-1,265
| -1% | -$8.04K | ﹤0.01% | 1814 |
|
|
2018
Q1 | $714K | Sell |
104,291
-921
| -0.9% | -$5.85K | ﹤0.01% | 2233 |
|
|
2017
Q4 | $692K | Sell |
105,212
-110
| -0.1% | -$672 | ﹤0.01% | 2247 |
|
|
2017
Q3 | $585K | Sell |
105,322
-144,720
| -58% | -$977K | ﹤0.01% | 2335 |
|
|
2017
Q2 | $1.93M | Sell |
250,042
-218,636
| -47% | -$1.85M | 0.01% | 1652 |
|
|
2017
Q1 | $4.22M | Buy |
468,678
+334,747
| +250% | +$3.49M | 0.01% | 1126 |
|
|
2016
Q4 | $1.45M | Buy |
133,931
+34,262
| +34% | +$457K | ﹤0.01% | 1912 |
|
|
2016
Q3 | $1.63M | Sell |
99,669
-46,236
| -32% | -$651K | 0.01% | 1752 |
|
|
2016
Q2 | $1.39M | Buy |
145,905
+34,167
| +31% | +$372K | ﹤0.01% | 1814 |
|
|
2016
Q1 | $1.57M | Buy |
111,738
+79,418
| +246% | +$822K | 0.01% | 1739 |
|
|
2015
Q4 | $350K | Sell |
32,320
-193,343
| -86% | -$1.75M | ﹤0.01% | 2592 |
|
|
2015
Q3 | $1.54M | Buy |
+225,663
| New | +$1.75M | ﹤0.01% | 1790 |
|
|
2014
Q2 | – | Sell |
-11,285
| Closed | -$89K | – | 3324 |
|
|
2014
Q1 | $89K | Buy |
+11,285
| New | +$84K | ﹤0.01% | 3046 |
|
Other funds holding NPTN
Guggenheim Capital's NPTN Position: Q3 2022 in Review
Guggenheim Capital sold out of NEOPHOTONICS CORP (NPTN) in Q3 2022, closing a stake of 102,036 shares — an estimated $1.6M sold.
Guggenheim Capital first reported a position in NPTN in Q1 2014 and held it in 17 quarters. The position peaked at $4.22M in Q1 2017. 2 funds tracked by Wall St. Rank hold NPTN as of Q3 2022.
- Guggenheim Capital reported no remaining NEOPHOTONICS CORP position as of Q3 2022 after selling out during the quarter.
- Guggenheim Capital sold 102,036 NEOPHOTONICS CORP shares in Q3 2022, an estimated $1.6M.
- Guggenheim Capital first reported a position in NEOPHOTONICS CORP in Q1 2014 and held it in 17 quarters.
- Guggenheim Capital's NEOPHOTONICS CORP position peaked at $4.22M in Q1 2017.
- 2 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2022.
Based on Guggenheim Capital's 13F filing for Q3 2022, filed 14 Nov 2022.